These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 27225507)
41. Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma. Funk RK; Moore EJ; García JJ; Harmsen WS; Stoddard DG; Vencio EF; Foote RL; Price KA; Ma DJ Head Neck; 2016 Apr; 38 Suppl 1():E1674-9. PubMed ID: 26667985 [TBL] [Abstract][Full Text] [Related]
42. Surgery Versus Radiotherapy for Early Oropharyngeal Tumors: a Never-Ending Debate. Monnier Y; Simon C Curr Treat Options Oncol; 2015 Sep; 16(9):42. PubMed ID: 26187797 [TBL] [Abstract][Full Text] [Related]
43. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan. Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582 [TBL] [Abstract][Full Text] [Related]
44. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606 [TBL] [Abstract][Full Text] [Related]
45. Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre. Lörincz BB; Möckelmann N; Busch CJ; Münscher A; Sehner S; Dalchow CV; Knecht R Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1028-33. PubMed ID: 25968617 [TBL] [Abstract][Full Text] [Related]
46. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom. O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476 [TBL] [Abstract][Full Text] [Related]
47. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck. Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654 [TBL] [Abstract][Full Text] [Related]
48. Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes. Troob S; Givi B; Hodgson M; Mowery A; Gross ND; Andersen PE; Clayburgh D Head Neck; 2017 Oct; 39(10):1969-1975. PubMed ID: 28758272 [TBL] [Abstract][Full Text] [Related]
49. Trans oral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience. Meccariello G; Bianchi G; Calpona S; Parisi E; Cammaroto G; Iannella G; Sgarzani R; Montevecchi F; De Vito A; Capaccio P; Pelucchi S; Vicini C Oral Oncol; 2020 Nov; 110():104889. PubMed ID: 32653838 [TBL] [Abstract][Full Text] [Related]
50. Transoral robotic surgery versus conventional surgery in treatment for squamous cell carcinoma of the upper aerodigestive tract. Hammoudi K; Pinlong E; Kim S; Bakhos D; Morinière S Head Neck; 2015 Sep; 37(9):1304-9. PubMed ID: 24816480 [TBL] [Abstract][Full Text] [Related]
51. Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma. Cracchiolo JR; Roman BR; Kutler DI; Kuhel WI; Cohen MA J Surg Oncol; 2016 Sep; 114(4):405-11. PubMed ID: 27392812 [TBL] [Abstract][Full Text] [Related]
52. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population. Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241 [TBL] [Abstract][Full Text] [Related]
53. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789 [TBL] [Abstract][Full Text] [Related]
54. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population. Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433 [TBL] [Abstract][Full Text] [Related]
55. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957 [TBL] [Abstract][Full Text] [Related]
57. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection. Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346 [TBL] [Abstract][Full Text] [Related]
58. Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC). Bußmann L; Laban S; Wittekindt C; Stromberger C; Tribius S; Möckelmann N; Böttcher A; Betz CS; Klussmann JP; Budach V; Muenscher A; Busch CJ BMC Cancer; 2020 Jul; 20(1):701. PubMed ID: 32727416 [TBL] [Abstract][Full Text] [Related]
59. Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neck. Carpenter TJ; Kann B; Buckstein MH; Ko EC; Bakst RL; Misiukiewicz KJ; Posner MR; Genden EM; Gupta V Ann Otol Rhinol Laryngol; 2014 Nov; 123(11):791-7. PubMed ID: 24847162 [TBL] [Abstract][Full Text] [Related]
60. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx. Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]